Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by CookieMonsteron May 26, 2016 5:52pm
107 Views
Post# 24908274

RE:RE:RE:RE:RE:60 product pipeline...

RE:RE:RE:RE:RE:60 product pipeline...The $250 mln. Fcf by year-end provides management a nice cushion.  If they used it to pay down debt, debt/ebitda wound be around 5.2x at year-end.  And it would be 4.5x year-end 2017 debt.    3.5x year-end 2018.  No need to pay down any more debt by then.  They would generate around $9 U.S. in fcf/share by that point.  So paying $55 U.S. Is such a great deal for private equity.  
<< Previous
Bullboard Posts
Next >>